Neurology · Brooklyn, NY
NPI
1205852845
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6917 Shore Rd
Brooklyn, NY, 11209
Phone (718) 680-8105
Groups this clinician bills Medicare through
Medicare paid, 2024
$485K
5,831 services
Medicare patients, 2024
566
Average age 72
Drug cost, 2024
$4.6M
7,505 prescriptions
Company payments, 2025
$439K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Idan Sharon was code 99213 (office e&m - established), 2,637 times for 473 patients. In total Idan Sharon billed 5,831 services in 19 codes, and Medicare paid $485K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,637 | 473 | $73.37 | $193K |
| 90833 Psychotherapy - Nongroup | Office | 1,990 | 327 | $56.83 | $113K |
| 95886 Electrical Nerve Conductivity | Office | 262 | 195 | $79.30 | $21K |
| 95812 Neurologic | Office | 214 | 211 | $295.48 | $63K |
| 99214 Office E&M - Established | Office | 188 | 137 | $105.12 | $20K |
| 95910 Electrical Nerve Conductivity | Office | 171 | 168 | $143.16 | $24K |
| 99204 Office E&M - New | Office | 124 | 124 | $136.99 | $17K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 104 | 102 | $159.72 | $17K |
| 95909 Electrical Nerve Conductivity | Office | 88 | 87 | $109.46 | $9,633 |
By year: 2022 $625K for 7,280 services; 2023 $782K for 8,659 services; 2024 $485K for 5,831 services.
Medicare prescription drug claims, 2024
In 2024, the drug Idan Sharon prescribed most often to Medicare patients was Escitalopram Oxalate, with 446 prescriptions and refills. In total Idan Sharon wrote 7,505 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Escitalopram Oxalate Generic | 446 | 766 | 87 | $3,837 |
| Rexulti Brexpiprazole | 360 | 404 | 72 | $581K |
| Clonazepam Generic | 284 | 296 | 66 | $2,944 |
| Xcopri Cenobamate | 281 | 291 | 30 | $344K |
| Quetiapine Fumarate Generic | 268 | 384 | 36 | $3,903 |
| Bupropion Xl Bupropion Hcl | 261 | 505 | 56 | $8,341 |
| Vraylar Cariprazine Hcl | 247 | 275 | 36 | $383K |
| Paroxetine Hcl Generic | 230 | 422 | 49 | $3,679 |
| Trintellix Vortioxetine Hydrobromide | 184 | 246 | 32 | $115K |
| Gabapentin Generic | 180 | 264 | 30 | $1,547 |
| Adlarity Donepezil Hcl | 173 | 191 | 24 | $84K |
| Alprazolam Generic | 171 | 173 | 42 | $1,421 |
| Ubrelvy Ubrogepant | 169 | 180 | 29 | $261K |
| Nurtec Odt Rimegepant Sulfate | 143 | 149 | 21 | $163K |
| Lorazepam Generic | 131 | 131 | 30 | $1,036 |
Brand drugs: 2,919 claims; generic drugs: 4,586 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Idan Sharon $439K ($439K in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $65K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 72 | $65K |
| Vanda Pharmaceuticals Inc. VNDA | 80 | $59K |
| Axsome Therapeutics, Inc. AXSM | 66 | $56K |
| E.R. Squibb & Sons, L.L.C. BMY | 59 | $53K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 66 | $51K |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 89 | $48K |
| Teva Pharmaceuticals USA, Inc. TEVA | 52 | $43K |
| Alkermes, Inc. ALKS | 42 | $36K |
| SK Life Science, Inc. | 18 | $13K |
| Pfizer Inc. PFE | 17 | $8,445 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.